WallStreetZenWallStreetZen

NASDAQ: DTIL
Precision Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for DTIL

Based on 1 analyst offering 12 month price targets for Precision Biosciences Inc.
Min Forecast
$3.00-75.73%
Avg Forecast
$3.00-75.73%
Max Forecast
$3.00-75.73%

Should I buy or sell DTIL stock?

Based on 1 analyst offering ratings for Precision Biosciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DTIL stock forecasts and price targets.

DTIL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-14

1 of 1

Forecast return on equity

Is DTIL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
24.42%

Forecast return on assets

Is DTIL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

DTIL revenue forecast

What is DTIL's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$47.9M-8.39%
Avg 2 year Forecast
$61.9M+18.39%
Avg 3 year Forecast
$77.1M+47.46%
DTIL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DTIL revenue growth forecast

How is DTIL forecast to perform vs Biotechnology companies and vs the US market?
Company
13.72%
Industry
48.24%
Market
9.9%
DTIL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DTIL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DTIL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DTIL$12.36$3.00-75.73%Buy
GMDA$0.37$4.75+1,194.28%Strong Buy
ALGS$0.67N/AN/A
PTN$2.98$70.00+2,248.99%Buy
ACHL$1.23$0.50-59.35%Sell

Precision Biosciences Stock Forecast FAQ

Is Precision Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DTIL) stock is to Buy DTIL stock.

Out of 1 analyst, 0 (0%) are recommending DTIL as a Strong Buy, 1 (100%) are recommending DTIL as a Buy, 0 (0%) are recommending DTIL as a Hold, 0 (0%) are recommending DTIL as a Sell, and 0 (0%) are recommending DTIL as a Strong Sell.

If you're new to stock investing, here's how to buy Precision Biosciences stock.

What is DTIL's revenue growth forecast for 2024-2026?

(NASDAQ: DTIL) Precision Biosciences's forecast annual revenue growth rate of 13.72% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 48.24%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.9%.

Precision Biosciences's revenue in 2024 is $52,287,000.On average, 1 Wall Street analysts forecast DTIL's revenue for 2024 to be $189,899,837, with the lowest DTIL revenue forecast at $189,899,837, and the highest DTIL revenue forecast at $189,899,837. On average, 1 Wall Street analysts forecast DTIL's revenue for 2025 to be $245,402,921, with the lowest DTIL revenue forecast at $245,402,921, and the highest DTIL revenue forecast at $245,402,921.

In 2026, DTIL is forecast to generate $305,663,413 in revenue, with the lowest revenue forecast at $305,663,413 and the highest revenue forecast at $305,663,413.

What is DTIL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DTIL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is DTIL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DTIL price target, the average DTIL price target is $3.00, with the highest DTIL stock price forecast at $3.00 and the lowest DTIL stock price forecast at $3.00.

The Wall Street analyst predicted that Precision Biosciences's share price could fall to $3.00 by Feb 14, 2025. The average Precision Biosciences stock price prediction forecasts a potential downside of 75.73% from the current DTIL share price of $12.36.

What is DTIL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DTIL) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.